Related Experiment Video
Updated: Jun 23, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis
Chenyang Wang1, Kyosuke Oishi1, Tadahiro Kobayashi1
1Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Abstract:
The bleomycin-induced scleroderma model is a well-established and dependable method for creating a mouse model of SSc (systemic sclerosis). In the field of skin connective tissue diseases, increasing evidence from clinical and animal experiments suggests that TLRs (Toll-like receptors) play an important role in several diseases. This study aimed to determine the role of TLR7 (Toll-like receptor 7) and TLR9 (Toll-like receptor 9) in the mechanisms of immune abnormalities and fibrosis in SSc. This study used TLR7-KO mice (TLR7-knockout mice with a balb/c background) and TLR9-KO mice (TLR9-knockout mice with a balb/c background) as well as WT mice (wild-type balb/c mice). All three kinds of mice were induced by BLM (bleomycin) in a scleroderma model as the experimental group; meanwhile, WT mice treated with PBS (phosphate-buffered saline) were used as the control group. We analyzed the fibrotic phenotype and the immunological abnormality phenotype of TLR7-deficient and TLR9-deficient mice in the SSc disease model using flow cytometry, RT-PCR (reverse transcription-polymerase chain reaction), a histological examination, and IHC (immunohistochemical staining). In a mouse model of SSc disease, the deletion of TLR7 attenuated skin and lung fibrosis, while the deletion of TLR9 exacerbated skin and lung fibrosis. The deletion of TLR7 resulted in a relative decrease in the infiltration and expression of various pro-inflammatory and fibrotic cells and cytokines in the skin. On the other hand, the deletion of TLR9 resulted in a relative increase in the infiltration and expression of various pro-inflammatory and cytokine-inhibiting cells and cytokines in the skin. Under the influence of pDCs (plasmacytoid dendritic cells), the balances of Beff/Breg (IL-6 + CD19 + B cell/IL-10 + CD19 + B cell), Th17/Treg (IL-17A + CD4 + T cell/Foxp3 + CD25 + CD4 + T cell), M1/M2 (CD86 + macrophage/CD206 + macrophage), and Th1/Th2 (TNFα + CD3 + CD4 + T cell/IL-4 + CD3 + CD4 + T cell) were biased towards the suppression of inflammation and fibrosis as a result of the TLR7 deletion. Comparatively, the balance was biased towards promoting inflammation and fibrosis due to the TLR9 deletion. In the SSc model, TLR7 promoted inflammation and fibrosis progression, while TLR9 played a protective role. These results suggest that TLR7 and TLR9 play opposite roles in triggering SSc to produce immune system abnormalities and skin fibrosis.
Insights
Toll-like receptor 7 (TLR7) deletion attenuated fibrosis in a systemic sclerosis (SSc) mouse model, reducing inflammation. Conversely, Toll-like receptor 9 (TLR9) deletion exacerbated SSc fibrosis, indicating opposite roles in disease progression.
Area of Science:
- Immunology
- Dermatology
- Fibrosis Research
Background:
- Systemic sclerosis (SSc) is a complex connective tissue disease with significant immune system involvement.
- Toll-like receptors (TLRs) are increasingly recognized for their role in inflammatory and fibrotic conditions.
- The precise roles of TLR7 and TLR9 in SSc pathogenesis remain incompletely understood.
Purpose of the Study:
- To investigate the specific roles of Toll-like receptor 7 (TLR7) and Toll-like receptor 9 (TLR9) in the immune abnormalities and fibrosis characteristic of systemic sclerosis (SSc).
- To elucidate the mechanisms by which TLR7 and TLR9 influence the inflammatory and fibrotic processes in a bleomycin-induced mouse model of SSc.
Main Methods:
- Utilized bleomycin (BLM)-induced scleroderma mouse models with wild-type (WT), TLR7-knockout (TLR7-KO), and TLR9-knockout (TLR9-KO) backgrounds.
- Employed flow cytometry, RT-PCR, histological examination, and immunohistochemical staining (IHC) to analyze fibrotic and immunological phenotypes.
- Assessed immune cell populations (pDCs, B cells, T cells, macrophages) and cytokine profiles to evaluate inflammatory and fibrotic responses.
Main Results:
- TLR7 deficiency significantly attenuated skin and lung fibrosis in the SSc model, accompanied by reduced pro-inflammatory and fibrotic cell/cytokine infiltration.
- TLR9 deficiency exacerbated skin and lung fibrosis, correlating with an increased infiltration of pro-inflammatory and cytokine-producing cells.
- TLR7 deletion promoted a shift towards suppressed inflammation and fibrosis, while TLR9 deletion favored inflammation and fibrosis progression, impacting immune cell balances (e.g., Th17/Treg, M1/M2).
Conclusions:
- TLR7 promotes inflammation and fibrosis progression in the SSc mouse model, suggesting a potential therapeutic target for reducing fibrotic burden.
- TLR9 exhibits a protective role in SSc, with its deletion worsening fibrotic outcomes, highlighting its complex involvement in immune regulation.
- TLR7 and TLR9 play opposing roles in the immune system abnormalities and skin fibrosis observed in systemic sclerosis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway

